Transcutaneous electrical nerve stimulation for reduction of pruritus in macular amyloidosis and lichen simplex

Journal of Dermatology

Volumn 38, Issue 6, 2011, Pages 546-552

  Yüksek, Jale ^a   Sezer, Engin ^a   Aksu, Murat ^a   Erkokmaz, Ünal ^a  

^a GAZIOSMANPASA UNIVERSITY   (Turkey)

Author keywords

Dermatology Life Quality Index; lichen simplex; macular amyloidosis; pruritus; transcutaneous electrical nerve stimulation; visual analogue scale

Indexed keywords

ADULT; AMYLOIDOSIS; ARTICLE; CLINICAL ARTICLE; DISEASE DURATION; ERYTHEMA; FEMALE; HUMAN; MACULAR AMYLOIDOSIS; MALE; NEURODERMATITIS; PRURITUS; QUALITY OF LIFE INDEX; RECURRENT DISEASE; THERAPY EFFECT; TRANSCUTANEOUS NERVE STIMULATION; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

ADULT; AMYLOIDOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEURODERMATITIS; PRURITUS; QUALITY OF LIFE; TRANSCUTANEOUS ELECTRIC NERVE STIMULATION;

EID: 79957923831     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2010.01081.x     Document Type: Article

References (27)

1. Engin B, Tufekci O, Yazici A, Ozdemir M,. The effect of transcutaneous electrical nerve stimulation in the treatment of lichen simplex: a prospective study. Clin Exp Dermatol 2009; 34: 324-328.
2. Heckmann M, Heyer G, Brunner B, Plewig G,. Botulinum toxin type A injection in the treatment of lichen simplex: an open pilot study. J Am Acad Dermatol 2002; 46: 617-619.
3. Konuk N, Koca R, Atik L, Muhtar S, Atasoy N, Bostanci B,. Psychopathology, depression and dissociative experiences in patients with lichen simplex chronicus. Gen Hosp Psychiatry 2007; 29: 232-235. (Pubitemid 46678210)
4. Solak O, Kulac M, Yaman M, et al. Lichen simplex chronicus as a symptom of neuropathy. Clin Exp Dermatol 2009; 34: 476-480.
5. Agrawal SK, Khurana S,. Lichen simplex. Indian Pediatr 2005; 42: 388. (Pubitemid 40663700)
6. Ostovari N, Mohtasham N, Oadras MS, Malekzad F,. 532-nm and 1064-nm Q-switched Nd:YAG laser therapy for reduction of pigmentation in macular amyloidosis patches. J Eur Acad Dermatol Venereol 2008; 22: 442-446. (Pubitemid 351436914)
7. Rasi A, Khatami A, Javaheri SM,. Macular amyloidosis: an assessment of prevalence, sex, and age. Int J Dermatol 2004; 43: 898-899. (Pubitemid 39642315)
8. Ozkaya-Bayazit E, Kavak A, Güngör H, Ozarmagan G,. Intermittent use of topical dimethyl sulfoxide in macular and papular amyloidosis. Int J Dermatol 1998; 37: 949-954. (Pubitemid 29012791)
9. Weyers W, Weyers I, Bonczkowitz M, Diaz-Cascajo C, Schill WB,. Lichen amyloidosus: a consequence of scratching. J Am Acad Dermatol 1997; 37: 923-928. (Pubitemid 28016620)
10. Hernández-Núñez A, Daudén E, Moreno de Vega MJ, Fraga J, Aragüés M, García-Díez A,. Widespread biphasic amyloidosis: response to acitretin. Clin Exp Dermatol 2001; 26: 256-259. (Pubitemid 34204358)
11. Pandhi R, Kaur I, Kumar B,. Lack of effect of dimethylsulphoxide in cutaneous amyloidosis. J Dermatolog Treat 2002; 13: 11-14. (Pubitemid 34163693)
12. Tanaka A, Arita K, Lai-Cheong JE, Palisson F, Hide M, McGrath JA,. New insight into mechanisms of pruritus from molecular studies on familial primary localized cutaneous amyloidosis. Br J Dermatol 2009; 161: 1217-1224.
13. Hudson LD,. Macular amyloidosis: treatment with Ultraviolet B. Cutis 1986; 38: 61-62. (Pubitemid 16062095)
14. Savk E, Savk O, Sendur F,. Transcutaneous electrical nerve stimulation offers partial relief in notalgia paresthetica patients with a relevant spinal pathology. J Dermatol 2007; 34: 315-319. (Pubitemid 46535952)
15. Whitaker C,. The use of TENS for pruritus relief in the burns patient: an individual case report. J Burn Care Rehabil 2001; 22: 274-276. (Pubitemid 32701619)
16. Tang WY, Chan LY, Lo KK, Wong TW,. Evaluation on the antipruritic role of transcutaneous electrical nerve stimulation in the treatment of pruritic dermatoses. Dermatology 1999; 199: 237-241.
17. Greaves MW,. Recent advances in pathophysiology and current management of itch. Ann Acad Med Singapore 2007; 36: 788-792. (Pubitemid 350219088)
18. Monk BE,. Transcutaneous electronic nerve stimulation in the treatment of generalized pruritus. Clin Exp Dermatol 1993; 18: 67-68. (Pubitemid 23043854)
19. Etter L, Myers SA,. Pruritus in systemic disease: mechanisms and management. Dermatol Clin 2002; 20: 459-472. (Pubitemid 34845923)
20. Finlay AY, Khan GK,. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216. (Pubitemid 24194579)
21. Shikiar R, Harding G, Leahy M, Lennox RD,. Minimal important difference (MID) of the Dermatology Life Quality Index (DLQI): results from patients with chronic idiopathic urticaria. Health Qual Life Outcomes 2005; 20: 36.
22. Revicki D, Willian MK, Saurat JH, et al. Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis. Br J Dermatol 2008; 158: 549-557. (Pubitemid 351239150)
23. Krueger GG, Langley RG, Finlay AY, et al. Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial. Br J Dermatol 2005; 153: 1192-1199. (Pubitemid 41779576)
24. Ortonne JP, Shear N, Shumack S, Henninger E, the CLEAR Multinational Study Group. Impact of efalizumab on patient-reported outcomes in high-need psoriasis patients: results of the international, randomized, placebo-controlled Phase III Clinical Experience Acquired with Raptiva (CLEAR) trial [NCT00256139]. BMC Dermatol 2005; 16: 13.
25. Melzack R, Wall PD,. Pain mechanism: a new theory. Science 1965; 150: 171-179.
26. Schmelz M,. Itch-mediators and mechanisms. J Dermatol Sci 2002; 28: 91-96. (Pubitemid 34155336)
27. Lyon CC, Howlett N, Harrison PV,. The effects of transcutaneous nerve stimulation on pruritus in dermatological patients. J Dermatolog Treat 1998; 9: 21-23. (Pubitemid 28163690)